Moderate riskFDA DrugClass II

Unichem bisoprolol/hydrochlorothiazide tablets recalled for impurity

Unichem Pharmaceuticals is recalling one lot of bisoprolol fumarate and hydrochlorothiazide tablets (2.5 mg/6.25 mg) because they contain higher-than-allowed levels of N-Nitroso Bisoprolol, a potentially harmful impurity. The affected lot was manufactured in India and distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check your bisoprolol/hydrochlorothiazide bottle for lot number GBHL24005A with expiration date 09/2026.
  2. If you have this lot, contact your pharmacy or doctor before stopping the medication.
  3. Do not abruptly stop taking your blood pressure medication without medical guidance.
  4. Return the affected medication to your pharmacy or follow FDA disposal instructions.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
1 Tower Center Blvd Ste 2200, N/A, East Brunswick, NJ, United States
Classification
Class II
Recall number
D-0301-2026

In the FDA's words

Description
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01 cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits. Lot # GBHL24005A, Exp Date: 09/2026 Distribution: US Nationwide and PR. Affected quantity: N/A
Hazard
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

Related topics

Industrial chemicalsDrugsSold nationwideMore from FDA Drug